Einloggen

Thematische Bibliographien / Actinium / Zeitschriftenartikel

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Actinium.

Zeitschriftenartikel zum Thema „Actinium“

Autor: Grafiati

Veröffentlicht am 4. Juni 2021

Zuletzt aktualisiert am 1. August 2024

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Actinium" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

WALL, GREG. "ACTINIUM." Chemical & Engineering News 81, no. 36 (September 8, 2003): 162. http://dx.doi.org/10.1021/cen-v081n036.p162.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Deblonde, Gauthier J. P., and Rebecca J. Abergel. "Active actinium." Nature Chemistry 8, no. 11 (October 21, 2016): 1084. http://dx.doi.org/10.1038/nchem.2653.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Gyurkocza, Boglarka, Rajneesh Nath, Stuart Seropian, Hannah Choe, Mark R. Litzow, Nebu V. Koshy, Patrick Stiff, et al. "Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies." Blood 138, Supplement 1 (November 5, 2021): 1791. http://dx.doi.org/10.1182/blood-2021-148497.

Der volle Inhalt der Quelle

Annotation:

Abstract Background: Several targeted therapies have been recently approved as treatment options for acute myeloid leukemia (AML), however, complete remissions (CR) in relapsed/refractory (R/R) patients remain low. Due to suboptimal responses to standard therapies, most of these patients do not receive an allogeneic hematopoietic cell transplant (HCT). In addition, AML patients ≥55 years have poor tolerance and high morbidity from a myeloablative HCT. The SIERRA trial (Study of Iomab-B in Elderly Relapsed or Refractory AML) has been investigating the use of Iomab-B, an 131I-labeled anti-CD45 m

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

Eliav, Ephraim, Sergei Shmulyian, Uzi Kaldor, and Yasuyuki Ishikawa. "Transition energies of lanthanum, actinium, and eka-actinium (element 121)." Journal of Chemical Physics 109, no. 10 (September 8, 1998): 3954–58. http://dx.doi.org/10.1063/1.476995.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Yushchenko, V., V. Gopka, A. V. Yushchenko, A. Shavrina, Ya Pavlenkо, and S. Vasil’eva. "ACTINIUM ABUNDANCES IN STELLAR ATMOSPHERES." Odessa Astronomical Publications 34 (December 3, 2021): 70–73. http://dx.doi.org/10.18524/1810-4215.2021.34.244288.

Der volle Inhalt der Quelle

Annotation:

This paper presents a study of radioactive actinium in the atmospheres of stars located in galaxies with different chemical evolution history – namely, Przybylski's Star (HD 101065) in the Milky Way and the red supergiant PMMR27 in the Small Magellanic Cloud; it also reports the findings of the previous research of the red supergiant RM 1-667 in the Large Magellanic Cloud and the red giant BL138 in the Fornax dwarf spheroidal galaxy. The actinium abundance is close to that of uranium in the atmospheres of certain stars in the Milky Way’s halo and in the atmosphere of Arcturus. The following ac

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Durrani, Matin. "From actinium to zinc." Physics World 32, no. 8 (August 2019): 50. http://dx.doi.org/10.1088/2058-7058/32/8/39.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Zielińska, B., and A. Bilewicz. "The hydrolysis of actinium." Journal of Radioanalytical and Nuclear Chemistry 261, no. 1 (2004): 195–98. http://dx.doi.org/10.1023/b:jrnc.0000030956.61947.c5.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Tsoupko-Sitnikov, V., Yu Norseev, and V. Khalkin. "Generator of actinium-225." Journal of Radioanalytical and Nuclear Chemistry Articles 205, no. 1 (April 1996): 75–83. http://dx.doi.org/10.1007/bf02040552.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Pratiwi, Anita Puji, Trapsilo Prihandono, and Sri Handono Budi Prastowo. "Numerical Solution of Radioactive Core Decay Activity Rate of Actinium Series Using Matrix Algebra Method." Jurnal Penelitian Pendidikan IPA 7, no. 3 (July 7, 2021): 395. http://dx.doi.org/10.29303/jppipa.v7i3.716.

Der volle Inhalt der Quelle

Annotation:

The Actinium 235 series is one of the radioactive series which is widely used as a raw material for reactors and nuclear activities. The existence of this series is found in several countries such as West USA, Canada, Australia, South Africa, Russia, and Zaire. The purpose of this study was to determine the activity value and the number of radioactive nucleus decay atoms on the actinium 235 rendered in a very long decay time of 4.3 x 109 years. The decay count in this study uses an algebraic matrix method to simplify the chain decay solution, which generally uses the concept of differential eq

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Hoffman, Darleane C. "Glenn Theodore Seaborg. 19 April 1912 — 25 February 1999." Biographical Memoirs of Fellows of the Royal Society 53 (January 2007): 327–38. http://dx.doi.org/10.1098/rsbm.2007.0021.

Der volle Inhalt der Quelle

Annotation:

Glenn T. Seaborg was a world-renowned nuclear chemist, educator, scientific adviser to ten US presidents, humanitarian, and Nobel laureate in chemistry. He is probably best known for his leadership of the team that in 1941 accomplished the first chemical separation and positive identification of plutonium and for his ‘revolutionary’ actinide concept in which he placed the first 14 elements heavier than actinium in the periodic table of elements as a 5f transition series under the lanthanide 4f transition series. He went on to be co-discoverer of nine elements beyond plutonium, culminating in 1

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Kozimor, Stosh, Enrique Batista, Kevin John, Eva Birnbaum, Veronika Mocko, Laura Lilley, Amanda Morgenstern, and Benjamin Stein. "Coordination Chemistry of +3 Actinium." Journal of Medical Imaging and Radiation Sciences 50, no. 4 (December 2019): S78—S79. http://dx.doi.org/10.1016/j.jmir.2019.11.041.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

Kozimor, Stosh, Enrique Batista, Kevin John, Eva Birnbaum, Veronika Mocko, Laura Lilley, Amanda Morgenstern, and Benjamin Stein. "Coordination Chemistry of +3 Actinium." Journal of Medical Imaging and Radiation Sciences 50, no. 1 (March 2019): S11. http://dx.doi.org/10.1016/j.jmir.2019.03.036.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

Dzhuzha, D., and S. Myasoyedov. "Radionuclide therapy with alpha-emitters." Radiation Diagnostics, Radiation Therapy, no. 4 (2019): 37–47. http://dx.doi.org/10.37336/2707-0700-2019-4-4.

Der volle Inhalt der Quelle

Annotation:

In this review the main streams of using alpha-emitters radium-223, actinium-225, bismuth-213, astatine-211 in complex treatment of malignant tumors are reviewed. The features of radiobiological actions of alpha-emission make its more effective in hundred times than beta-emission. The efficacy of this kind of radionuclide therapy does not dependent from chemoresistance and radioresistance to beta-emitters. The results of experimental and initial clinical investigation, which indicate on promising further investigations in this direction, were revealed. Key words: radionuclide therapy of malign

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Kazakov, A. G., B. L. Garashchenko, R. Yu Yakovlev, S. E. Vinokurov, S. N. Kalmykov, and B. F. Myasoedov. "Generator of Actinium-228 and a Study of the Sorption of Actinium by Carbon Nanomaterials." Radiochemistry 62, no. 5 (May 2020): 592–98. http://dx.doi.org/10.1134/s1066362220050057.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Putri, Maharani Karunia, Albertus Djoko Lesmono, and Alex Harijanto. "SIMULASI ENERGI IKAT DAN ENERGI DISINTEGRASI PELURUHAN UNSUR RADIOAKTIF DERET AKTINIUM BERDASARKAN MODEL INTI TETESAN CAIRAN (TELAAH KLASIK)." JURNAL PEMBELAJARAN FISIKA 10, no. 1 (March 31, 2021): 22. http://dx.doi.org/10.19184/jpf.v10i1.23583.

Der volle Inhalt der Quelle

Annotation:

The purpose of this research is to make simulation with Matlab application to calculate the binding energy and disintegration energy of Actinium series based of liquid drop model approach. This research is experimental description. The steps: 1) prepare literature studies of elements in the radioactive process; 2) reviewing some literatures; 3) do calculation simulation; 4) analyze and discuss the results of calculations; 5) conclude the research results. The calculation results show that the binding energy value of the Actinium Series based of liquid drop model approach is in accordance with

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Rick Mullin. "SpectronRX plans actinium-225 in Indiana." C&EN Global Enterprise 100, no. 22 (June 20, 2022): 11. http://dx.doi.org/10.1021/cen-10022-buscon14.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Aldrich, Kelly E., Mila Nhu Lam, Cecilia Eiroa-Lledo, Stosh A. Kozimor, Laura M. Lilley, Veronika Mocko, and Benjamin W. Stein. "Preparation of an Actinium-228 Generator." Inorganic Chemistry 59, no. 5 (February 16, 2020): 3200–3206. http://dx.doi.org/10.1021/acs.inorgchem.9b03563.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Guminski, C. "The Ac-Hg (actinium-mercury) system." Journal of Phase Equilibria 16, no. 4 (August 1995): 332. http://dx.doi.org/10.1007/bf02645291.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

Venkatraman, M., J. P. Neumann, and D. E. Peterson. "The Ac-Cr (Actinium-Chromium) system." Bulletin of Alloy Phase Diagrams 6, no. 5 (October 1985): 413–14. http://dx.doi.org/10.1007/bf02869495.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Kosynkin, V. D., S. D. Moiseev, and V. S. Vdovichev. "Cleaning rare earth elements from actinium." Journal of Alloys and Compounds 225, no. 1-2 (July 1995): 320–23. http://dx.doi.org/10.1016/0925-8388(94)07132-2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Rick Mullin. "Firms launch an actinium-225 venture." C&EN Global Enterprise 101, no. 36 (October 30, 2023): 14. http://dx.doi.org/10.1021/cen-10136-buscon14.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Peterson, D. E. "The Ac−Pt (Actinium-Platinum) system." Bulletin of Alloy Phase Diagrams 10, no. 4 (August 1989): 471–72. http://dx.doi.org/10.1007/bf02882382.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Rahman, A. K. M. Rezaur, Mahathe Hasan Babu, Mustofa Khalid Ovi, Md Mahiuddin Zilani, Israt Sultana Eithu, and Amit Chakraborty. "Actinium-225 in Targeted Alpha Therapy." Journal of Medical Physics 49, no. 2 (April 2024): 137–47. http://dx.doi.org/10.4103/jmp.jmp_22_24.

Der volle Inhalt der Quelle

Annotation:

The utilization of actinium-225 (225Ac) radionuclides in targeted alpha therapy for cancer was initially outlined in 1993. Over the past two decades, substantial research has been conducted, encompassing the establishment of 225Ac production methods, various preclinical investigations, and several clinical studies. Currently, there is a growing number of compounds labeled with 225Ac that are being developed and tested in clinical trials. In response to the increasing demand for this nuclide, production facilities are either being built or have already been established. This article offers a co

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Toro-González, M., R. Copping, S. Mirzadeh, and J. V. Rojas. "Multifunctional GdVO4:Eu core–shell nanoparticles containing 225Ac for targeted alpha therapy and molecular imaging." Journal of Materials Chemistry B 6, no. 47 (2018): 7985–97. http://dx.doi.org/10.1039/c8tb02173b.

Der volle Inhalt der Quelle

Annotation:

Development of actinium-225 doped Gd<sub>0.8</sub>Eu<sub>0.2</sub>VO<sub>4</sub> core–shell nanoparticles as multifunctional platforms for multimodal molecular imaging and targeted radionuclide therapy.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

Diamond, W. T., and C. K. Ross. "Actinium-225 production with an electron accelerator." Journal of Applied Physics 129, no. 10 (March 14, 2021): 104901. http://dx.doi.org/10.1063/5.0043509.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

Brown, M. Alex. "Separation of radium and actinium using zirconia." Applied Radiation and Isotopes 185 (July 2022): 110238. http://dx.doi.org/10.1016/j.apradiso.2022.110238.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Skliarova, Hanna, Stephan Heinitz, Jasper Mermans, Dominic Maertens, Alexey Stankovskiy, Dennis Elema, and Thomas Cardinaels. "Towards Actinium-225 production at SCK CEN." Nuclear Medicine and Biology 96-97 (May 2021): S80—S81. http://dx.doi.org/10.1016/s0969-8051(21)00398-x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

Ürer, Güldem, and Leyla Özdemir. "The level structure of singly-ionized actinium." Journal of the Korean Physical Society 61, no. 3 (August 2012): 353–58. http://dx.doi.org/10.3938/jkps.61.353.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Kotovskii, A. A., N. A. Nerozin, I. V. Prokof’ev, V. V. Shapovalov, Yu A. Yakovshchits, A. S. Bolonkin, and A. V. Dunin. "Isolation of actinium-225 for medical purposes." Radiochemistry 57, no. 3 (May 2015): 285–91. http://dx.doi.org/10.1134/s1066362215030091.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

Harris, Jack. "Actinium to zirconium and all in between." Physics World 15, no. 2 (February 2002): 46. http://dx.doi.org/10.1088/2058-7058/15/2/43.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Du, Yong, Angel Cortez, Anders Josefsson, Mohammadreza Zarisfi, Rebecca Krimins, Eleni Liapi, and Jessie R. Nedrow. "Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma." PLOS ONE 17, no. 1 (January 21, 2022): e0261982. http://dx.doi.org/10.1371/journal.pone.0261982.

Der volle Inhalt der Quelle

Annotation:

Hepatocellular carcinoma is the most common primary liver cancer and the fifth most frequently diagnosed cancer worldwide. Most patients with advanced disease are offered non-surgical palliative treatment options. This work explores the first alpha-particle emitting radioembolization for the treatment and monitoring of hepatic tumors. Furthermore, this works demonstrates the first in vivo simultaneous multiple-radionuclide SPECT-images of the complex decay chain of an [225Ac]Ac-labeled agent using a clinical SPECT system to monitor the temporal distribution. A DOTA chelator was modified with a

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

A. Scheinberg, David, and Michael R. McDevitt. "Actinium-225 in Targeted Alpha-Particle Therapeutic Applications." Current Radiopharmaceuticalse 4, no. 4 (October 1, 2011): 306–20. http://dx.doi.org/10.2174/1874471011104040306.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Ferrier, Maryline G., Benjamin W. Stein, Enrique R. Batista, John M. Berg, Eva R. Birnbaum, Jonathan W. Engle, Kevin D. John, Stosh A. Kozimor, Juan S. Lezama Pacheco, and Lindsay N. Redman. "Synthesis and Characterization of the Actinium Aquo Ion." ACS Central Science 3, no. 3 (February 2017): 176–85. http://dx.doi.org/10.1021/acscentsci.6b00356.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Abergel, Rebecca, and Leticia Arnedo-Sanchez. "Challenges of actinium coordination chemistry for nuclear medicine." Journal of Medical Imaging and Radiation Sciences 50, no. 4 (December 2019): S111. http://dx.doi.org/10.1016/j.jmir.2019.11.124.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Abergel, Rebecca, and Leticia Arnedo-Sanchez. "Challenges of actinium coordination chemistry for nuclear medicine." Journal of Medical Imaging and Radiation Sciences 50, no. 1 (March 2019): S39. http://dx.doi.org/10.1016/j.jmir.2019.03.119.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Al-DARGAZELLI, Shetha Selman, and Nejla'a Salih Al-ALI. "Actinium-228 in Natural Background Gamma Radiation Spectrum." Journal of Nuclear Science and Technology 23, no. 8 (August 1986): 740–44. http://dx.doi.org/10.1080/18811248.1986.9735047.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Sakamoto, Yoshiaki, Tomoaki Ishii, Satora Inagawa, Yasuyoshi Gunji, Shinichi Takebe, Hiromichi Ogawa, and Tomozo Sasaki. "Sorption Characteristics of Actinium and Protactinium onto Soils." Journal of Nuclear Science and Technology 39, sup3 (November 2002): 481–84. http://dx.doi.org/10.1080/00223131.2002.10875511.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Fry, C., and M. Thoennessen. "Discovery of actinium, thorium, protactinium, and uranium isotopes." Atomic Data and Nuclear Data Tables 99, no. 3 (May 2013): 345–64. http://dx.doi.org/10.1016/j.adt.2012.03.002.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Miller, Maurice O., and Dionne A. Miller. "The Technological Enhancement of Normally Occurring Radioactive Materials in Red Mud due to the Production of Alumina." International Journal of Spectroscopy 2016 (March 16, 2016): 1–6. http://dx.doi.org/10.1155/2016/4589460.

Der volle Inhalt der Quelle

Annotation:

This study investigates the level of technological enhancement of normally occurring radioactive materials (TENORM) in the red mud waste due to the production of alumina in Jamaica. Technological enhancements factors (TEF) were determined for the uranium, thorium, actinium series, their progenies, and the nonseries potassium-40 using gamma spectrometry. The study concluded that bauxite production technologically enhances the uranium progenies Th-234, Pb-214, Bi-214, and Pa-234 and the thorium-232 progenies Ac-228, Pb-212, and Bi-212 in red mud. The actinium series was technologically enhanced,

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

Harvey, James T. "NorthStar Perspectives for Actinium-225 Production at Commercial Scale." Current Radiopharmaceuticals 11, no. 3 (October 22, 2018): 180–91. http://dx.doi.org/10.2174/1874471011666180515123848.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Abou, Diane S., Patrick Zerkel, James Robben, Mark McLaughlin, Tim Hazlehurst, David Morse, Thaddeus J. Wadas, et al. "Radiopharmaceutical Quality Control Considerations for Accelerator-Produced Actinium Therapies." Cancer Biotherapy and Radiopharmaceuticals 37, no. 5 (June 1, 2022): 355–63. http://dx.doi.org/10.1089/cbr.2022.0010.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Weigand, Anna, Xiaoyan Cao, Tim Hangele, and Michael Dolg. "Relativistic Small-Core Pseudopotentials for Actinium, Thorium, and Protactinium." Journal of Physical Chemistry A 118, no. 13 (March 25, 2014): 2519–30. http://dx.doi.org/10.1021/jp500215z.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Thierer, Laura M., and Neil C. Tomson. "The Actinium Aqua Ion: A Century in the Making." ACS Central Science 3, no. 3 (March 7, 2017): 153–55. http://dx.doi.org/10.1021/acscentsci.7b00074.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

Young Oh, Se, Kyo Chul Lee, Ilhan Lim, Haijo Jung, and Sang Moo Lim. "Development of Actinium-225 Production Method using Liquid Target." Journal of Medical Imaging and Radiation Sciences 50, no. 4 (December 2019): S75. http://dx.doi.org/10.1016/j.jmir.2019.11.032.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

Cutler, C. "US DOE tri-lab effort to produce actinium-225." Nuclear Medicine and Biology 72-73 (July 2019): S8. http://dx.doi.org/10.1016/s0969-8051(19)30212-4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

Zhang, Chao, Zhi-Jian Li, Hong Jiang, Xue-Ning Hu, Guo-Hua Zhong, and Yue-Hua Su. "Thermodynamic and mechanical properties of actinium and lanthanum dihydride." Journal of Alloys and Compounds 616 (December 2014): 42–46. http://dx.doi.org/10.1016/j.jallcom.2014.07.087.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Young Oh, Se, Kyo Chul Lee, Ilhan Lim, Haijo Jung, and Sang Moo Lim. "Development of Actinium-225 Production Method using Liquid Target." Journal of Medical Imaging and Radiation Sciences 50, no. 1 (March 2019): S9. http://dx.doi.org/10.1016/j.jmir.2019.03.027.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Kennel, Stephen J., Martin W. Brechbiel, Diane E. Milenic, Jeffrey Schlom та Saed Mirzadeh. "Actinium-225 Conjugates of MAb CC49 and Humanized ΔCH2CC49". Cancer Biotherapy and Radiopharmaceuticals 17, № 2 (квітень 2002): 219–31. http://dx.doi.org/10.1089/108497802753773847.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Deal, Kim A., Ila A. Davis, Saed Mirzadeh, Stephen J. Kennel, and Martin W. Brechbiel. "Improved in Vivo Stability of Actinium-225 Macrocyclic Complexes." Journal of Medicinal Chemistry 42, no. 15 (July 1999): 2988–92. http://dx.doi.org/10.1021/jm990141f.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

Chen, Xiaoyuan, Min Ji, Chien M. Wai, Xiaoyuan Chen, and Darrell R. Fisher. "Carboxylate-derived calixarenes with high selectivity for actinium-225." Chemical Communications, no. 3 (1998): 377–78. http://dx.doi.org/10.1039/a706776c.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!